Related Experiment Video
Updated: Jan 11, 2026

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Type 2 Inflammatory Phenotypes in Chronic Obstructive Pulmonary Disease and Asthma: Similarities and Differences
Shenghan Gao1,2, Xiaoju Liu2
1The First Clinical Medical College, Lanzhou University, Lanzhou, People's Republic of China.
Type 2 inflammation in asthma and chronic obstructive pulmonary disease (COPD) shares similarities but has distinct features. Understanding these differences is key for personalized treatment strategies in airway diseases.
Area of Science:
- Pulmonology
- Immunology
- Inflammation Research
Background:
- Asthma and COPD are prevalent airway diseases with increasing incidence and mortality.
- Inflammatory phenotypes (type 2, non-type 2) differentiate these diseases based on immune cell involvement.
- Type 2 inflammation in COPD is a growing research focus, necessitating comparative understanding with asthma.
Purpose of the Study:
- To systematically review and analyze literature on type 2 inflammation in COPD and asthma.
- To elucidate similarities and differences in inflammatory mechanisms, clinical features, biomarkers, and treatment responses.
- To provide insights for developing individualized treatment strategies and improving patient outcomes.
Main Methods:
- Comprehensive literature search of Chinese and English studies on COPD, asthma, and type 2 inflammation.
- Systematic review and analysis of identified research papers.
- Comparative analysis of inflammatory mechanisms, clinical presentations, biomarkers, and therapeutic targets.
Main Results:
- Identified shared and distinct inflammatory pathways between type 2 COPD and asthma.
- Detailed comparison of clinical features, diagnostic biomarkers, and treatment responses.
- Highlighted the emergence of type 2 inflammation as a significant phenotype in COPD research.
Conclusions:
- Understanding the nuances of type 2 inflammation in COPD and asthma is crucial for effective management.
- Further research into underlying mechanisms can lead to novel therapies for unmet needs.
- Individualized treatment approaches based on inflammatory phenotypes can enhance patient outcomes and reduce disease burden.
More Related Videos
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

